Cynomolgus Glypican-3/GPC3 protein (Recombinant) (C-His) (STJP020282)

SPECIFICATIONS
HostHEK293 cells
ConjugationUnconjugated
ImmunogenRecombinant Cynomolgus Glypican-3/GPC3 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln25-His559) of cynomolgus Glypican-3/GPC3 (Accession #XP_005594665.1) fused with His tag at the C-terminus.
STJP020282-100
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRecombinant-Cynomolgus Glypican-3/GPC3-C-His protein was developed in hek293 cells using the region Gln25-His559. For use in research applications.
HostHEK293 cells
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ConjugationUnconjugated
Storage InstructionStore at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Determination Method< 1 EU/Mu g of the protein by LAL method.

Target Information

ImmunogenRecombinant Cynomolgus Glypican-3/GPC3 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln25-His559) of cynomolgus Glypican-3/GPC3 (Accession #XP_005594665.1) fused with His tag at the C-terminus.
Immunogen RegionGln25-His559
Immunogen SequenceQPPPPPPDATCHQVRSFFQR LQPGLKWVPETPVPGSDLQV CLPKGPTCCSRKMEEKYQLT ARLNMEQLLQSASMELKFLI IQNAAVFQEAFEIVVRHAKN YTNAMFKNNYPSLTPQAFEF VGEFFTDVSLYILGSDINVD DMVNELFDSLFPVIYTQLMN PGLPDSALDINECLRGARRD LKVFGNFPKLIMTQVSKSLQ VTRIFLQALNLGIEVINTTD HLKFSKDCGRMLTRMWYCS

Additional Info

Background Glypican-3 is a protein, which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed.

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins